Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Biocon Limited
Press Release Sep 18 2025
Business
Sep 18 2025
5 min read

Press Release Sep 18 2025

Biocon Limited has informed the Exchange regarding a press release dated September 18, 2025, titled "Biocon Biologics Yesafili® (aflibercept) Now Publicly Funded in Ontario, Canada for the Advanced Treatment of Patients with Retinal Diseases".

View Attachment